Aerska

Discovery Portfolio Manager

PhD preferred; PMP qualification ideal; 5–10+ years in biotech/pharma with exposure to antibody therapeutics, oligonucleotides, or conjugates; managing complex R&D programs; collaboration with internal and external partners.

Analytical CMC Lead

PhD in analytical chemistry or related field; 5-7 years CMC analytical development in oligonucleotide/RNA therapeutics; experience with IP-RP-HPLC, IEX, SEC, CE, LC-MS/MS; IND/CTA submissions; manage CDMOs/CROs.

Financial Accountant (0.6 - 1 FTE)

Financial Accountant

Fully qualified accountant with hands-on experience in lean finance environments; strong technical accounting and communication skills; proficient in Excel and accounting systems.

Senior Scientist – Computational siRNA Lead Development

Scientist

PhD in computational biology or related; extensive drug discovery in RNA-targeted therapeutics; hands-on transcriptome off-target analysis; strong Python/R; experience building computational workflows.

Principal Scientist - siRNA Lead Development

Principal Scientist

PhD in molecular biology or related field; extensive siRNA therapeutics experience; lead optimization and candidate nomination experience; strong RNA interference knowledge; collaboration with bioinformatics; in vitro/in vivo data interpretation.

Title	Location	Date
Discovery Portfolio Manager Full Time · 5+ YOE Stevenage, England, United Kingdom · Onsite	Stevenage, England, United Kingdom Onsite	Apr 28, 2026
Analytical CMC Lead Full Time · 5+ YOE Stevenage or Dublin or Boston · Hybrid	Stevenage or Dublin or Boston Hybrid	Apr 15, 2026
Financial Accountant (0.6 - 1 FTE) Part Time, Full Time Dublin, /, Ireland · Onsite	Dublin, /, Ireland Onsite	Mar 17, 2026
Senior Scientist – Computational siRNA Lead Development Full Time · 2+ YOE Dublin or Boston or Stevenage · Remote	Dublin or Boston or Stevenage Remote	Mar 17, 2026
Principal Scientist - siRNA Lead Development Full Time Stevenage, England, United Kingdom · Onsite	Stevenage, England, United Kingdom Onsite	Mar 17, 2026

Name	Aerska
Headquarters	IE
Industries	BiotechnologyPharmaceuticals
Activities	Developing RNAi therapeuticsNeurodegenerative disease researchDrug discovery for CNSAntibody-oligonucleotide conjugate developmentBrain shuttle delivery technology
Type	Private
Employees	30
Tagline	Developing RNA-based therapies for neurological diseases.
Founded	2,025
Website	aerska.com
Latest Funding Round	Series A
Latest Funding Year	2,026
Latest Funding Amount	39,000,000
Latest Investors	EQT Life Sciencesage1

Aerska

About Aerska